Series A led by Armira Growth raising a total of 20,000,000 EUR. Existing investors Wellington Partners, Crane Venture Partners and Ever Pharma participated. Company previously raised a 4,500,000 EUR pre-seed in 2023. myReha is MDR-IIa certified and part of digital rehab aftercare; reimbursement by multiple statutory and private insurers.
About Nyra Health
Vienna-based HealthTech company offering a multimodal, AI-driven digital neurorehabilitation platform (myReha) integrated into routine care to support language, cognition and motor therapy after neurological injury.
Vienna, Austria
Read Company Profile
Source: https://brutkasten.com/artikel/nyra-health-aus-wien-holt-investment-in-hoehe-von-20-millionen-euro
Frequently Asked Questions
What type of funding round did Nyra Health raise?
Nyra Health raised a series-a round.
How much did Nyra Health raise in its series-a?
Nyra Health raised $20,000,000 EUR in its series-a.
When did Nyra Health raise its series-a?
Nyra Health raised its series-a on 2026-02-24.
Who invested in Nyra Health's series-a?
The investors in Nyra Health's series-a are: Armira Growth, Wellington Partners, Crane Venture Partners, Ever Pharma.
What type of investment was Nyra Health's series-a?
Nyra Health's series-a was a equity investment.
How will Nyra Health use the funds from its series-a?
Nyra Health plans to use the funds for: Expand technology platform across DACH region, Integrate additional clinic groups, Expand reimbursement models in Germany, Austria and Switzerland, Prepare entry into the US market (planned go-to-market with an international pharma partner), Further technological development, including expansion of multimodal AI models for therapy interaction and diagnostics, Fund and validate research collaboration with leading US research universities (funded project of 4.2 million euro).